FIND YOUR VIVEVE SOLUTIONS PROVIDER
As a women’s health & wellness company that puts science first, we encourage you to speak with a local provider to learn more about how the Viveve Solutions can help you!
The Viveve System is indicated for the treatment of vaginal laxity, sexual function or urinary incontinence in more than 50 countries, and use in general surgery for electrocoagulation and hemostasis in the United States.
InControl Product Provider
Alaska, USA 99603
The Viveve Treatment
A nonsurgical radiofrequency treatment that rebuilds tissue. It works via a small probe which emits cryogen cooling to protect the tissue and radiofrequency waves to heat the tissue. This prompts the production of new collagen.
- A single 30-45 minute session
- Safe and comfortable
- Respectable and discreet
InControl Products by Viveve
Pelvic ﬂoor muscles are part of your core muscle group and just like other muscles, they need regular exercise to stay strong–especially after childbirth. InControl Products by Viveve are at home devices that strengthen the pelvic ﬂoor and calm the detrusor muscles, to control urination and prevent bladder leakage.
- 10–12 minutes a day for 3–6 months
- 90% effective in treating daily incontinence episodes
- FDA indication for urge, stress, and mixed urinary incontinence and fecal incontinence
Finding the nearest
Providers is simple
Search by Keyword: You can enter a practices name, or a providers name, to quickly find a specific provider. Submit a request if you would like your current healthcare professional to become a Viveve provider.
Search the Map: Simply hover over the map with your mouse or fingers and zoom in on your preferred area. Click on the icon to 'Read More' and view the individual listing page.
345 Inverness Drive South • Building B, Suite 250 • Englewood, CO 80112
Content provided on this site may not be applicable for every region. Please abide by your regional indication as follows: The Viveve System® is indicated for treatment of the vaginal introitus, after vaginal childbirth, to improve sexual function in: Australia, Brazil, Canada, Chile, Colombia, Costa Rica, Dominican Republic, Hong Kong, Japan, Malaysia, Mexico, Panama, Philippines, Singapore, United Arab Emirates, Uruguay, and Venezuela. The Viveve System is indicated for treatment of vaginal laxity in: Bahrain, EU, Iceland, Iran, Korea, Kuwait, Lebanon, Liechtenstein, Norway, Qatar, South Africa, Switzerland, Turkey, and Ukraine. The Viveve System is indicated for use in general surgery for electrocoagulation and hemostasis in: Korea, Peru, Taiwan, Thailand, and the United States.
Manage Your Listing
Viveve, Inc. 2019 All Rights Reserved